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Absolute requirement of glucocorticoid for expression of the casein
gene in the presence of prolactin
(BALB/c mouse/whole mammary gland in vitro/casein mRNA/cDNA hybridization/cortisol retention)

RANJAN GANGULY, NIVEDITA GANGULY, NOZER M. MEHTA, AND M. R. BANERJEE
Tumor Biology Laboratory, School of Life Sciences, University of Nebraska, 201 Lyman Hall, Lincoln, Nebraska 68588

Communicated by Myron K. Brakke, July 22,1980

ABSTRACT
Second thoracic mammary glands of immature
BALB/c female mice were stimulated to pregnancy-like lobuloalveolar (LA) development after 6 days of incubation in a
corticosteroid-free step I culture medium containing insulin,
prolactin, estradiol, progesterone, and growth hormone. A low
basal level (0.0009%) of casein mRNA (mRN4.,) sequences was
detectable in the LA glands by a specific cDNA probe. Subsequent incubation of the LA glands for 3 days in medium containing insulin and prolactin or insulin and cortisol failed to
elicit mRNAesn above the basal level, indicating that neither
prolactin nor cortisol alone can support casein gene expression.
However, an increase in mRNA. levels was observed when the
3-day incubation with insulin and cortisol or insulin and prolactin was followed by 3 days of culture in presence of insulin,
prolactin, and cortisol. When a 3-day incubation with insulin
and prolactin was followed by 3 days in insulin and cortisol
medium, mRNAes. levels in the gland remained similar to the
basal level. However, a 20-fold increase in the mRNAesn levels
ensued when the LA glands were sequentially incubated for 3
days in insulin and cortisol and then for another 3 days in insulin
and prolactin medium. After a preincubation in insulin and
cortisol medium, the LA glands retained residual cortisol during
subsequent incubation in insulin and prolactin medium, and
the mRNAes. levels in these glands were related to the level of
residual cortisol present. When mRNAesn and the residual cortisol level reached a minimum, addition of fresh cortisol to the
medium caused a 20-fold increase in the mRNAesn levels. This
indicates that cortisol is a limiting factor in insulin and prolactin
medium and its presence is absolutely required for casein gene
expression.

The requirement that prolactin and cortisol be present for
lactogenesis was delineated over 2 decades ago (1, 2). Since then,
numerous studies have shown that, during lactation, a marked
increase of mammary cell RNA and protein, including casein,
is dependent upon stimulation by prolactin and cortisol (3, 4).
We have shown that cortisol is required for the maintenance
of casein-synthesizing polysomes, poly(A)+RNA synthesis, and
casein mRNA (mRNAsn) accumulation in the lactating
mammary gland of the mouse (5-7). Moreover, a regulatory
action of the glucocorticoid on transcription of the casein gene
in the mammary gland in vivo has been demonstrated (7).
However, complexities in the animal limit elucidation of the
discrete role of polypeptide and steroid hormones which regulate specific expression of the casein gene in breast cells.
Fragments of mammary tissue from pregnant mice were
demonstrated to be capable of synthesizing casein in a culture
medium containing the lactogenic hormones plus insulin (8).
This provided an in vitro model for studying molecular responses of the mammary cells to prolactin and glucocorticoid

action in a chemically defined medium containing insulin,
which is needed for viability of the mammary parenchyma in
vitro (9). Subsequently, it was observed that prolactin stimulates
casein synthesis as well as transcriptional activity in the explants
that were preincubated with cortisol (10, 11). It was then concluded that prolactin acts as an inducer for casein gene expression. With a similar experimental protocol, recently it has
been observed that the endogenous mRNA<,,, normally present
in pregnant rat mammary tissue, is decreased after an initial
incubation of the explants with cortisol (12, 13). Subsequent
incubation with prolactin in a cortisol-free medium results into
a pronounced increase of mRNAf, transcription in the explants
(13). Based on these findings it has been concluded that prolactin is "the" hormone-required for expression of the casein
gene, and cortisol is not necessary for evoking this response in
the mammary cells (12, 13). This conclusion assumes that the
explants, preincubated with cortisol, remain completely free
of the steroid hormone during the subsequent short-term culture with prolactin alone. However, mammary tissue is known
to retain steroid hormones, including cortisol, for a prolonged
period of time (14, 15). The concentration of the residual glucocorticoid has been reported to be sufficient to support casein
synthesis, measured by [32P]orthophosphate uptake, in the explants in presence of prolactin alone (15). This raises the important question of whether responses of the mammary cells
to prolactin measured (during last 15 years) in explants preexposed to cortisol reflect an action of the polypeptide hormone
alone or a synergistic action of prolactin and the residual cortisol
retained by the tissue.
Earlier we have shown that, in a two-step culture model of
the whole mammary organ, the immature parenchyma develops pregnancy-like lobuloalveolar (LA) structures in a step
I corticosteroid-free medium containing insulin, prolactin,
growth hormone, and the ovarian steroids (16). The LA glands
containing the secretory structures elicit only a basal level of
mRNAmn. In the step II culture medium containing insulin,
prolactin, and cortisol, abundant mRNA, accumulates in the
LA glands within 24 hr. and the concentration of the specific
sequences increases 255-fold during the 9-day incubation (16).
This increase of mRNA,sn is accompanied by accumulation of
casein in the gland (17). The possibility of a carryover of residual
cortisol from step I to step II medium is virtually absent in this
unique in vitro model, because the step I mammogenic medium does not contain any adrenal glucocorticoid. In the present
study, this two-step culture model of the whole mammary organ
was used to assess the action of the two principal lactogenic
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Abbreviations: LA glands, lobuloalveolar mammary glands obtained
after 6-day incubation in mammogenic medium; mRNA,,n, casein
mRNA; Rot, mol of ribonucleotide per liter X time (sec); Rotl/2, Rot
necessary for 50% hybridization.
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hormones, prolactin and cortisol, on expression of the casein
gene in a controlled hormonal environment. The results clearly
show that expression of the casein gene is not inducible by either
prolactin or the adrenal glucocorticoid alone.
MATERIALS AND METHODS
Organ Culture. Immature 3- to 4-week-old BALB/c female
mice obtained through the National Cancer Institute (Bethesda,
MD) were used. The procedures for whole mammary gland
organ culture have been described (16, 18, 19). In the present
study the entire thoracic glands of the estrogen/progesterone
primed mice were first incubated for 6 days in a step I mammogenic medium containing insulin, prolactin, estradiol, progesterone, and growth hormone for pregnancy-like LA growth.
The LA glands were then incubated in medium with different
combinations of insulin, prolactin, and cortisol for various time
intervals. Incubations were done at 370C in a 95% 02/5% CO2
atmosphere. Medium was changed on alternate days during the
initial step I culture and then every 24 hr subsequently.
Assessment of [3H]Cortisol Retention by the Mammary
Gland. After step I culture in cortisol-free medium, the LA
glands were first incubated for 48 hr in insulin and cortisol (each
at 5 ,ug/ml). During the last 24 hr the medium contained 5 gCi
of [3H]cortisol (New England Nuclear, 93 Ci/mmol; 1 Ci = 3.7
X 101 becquerels) per ml. Subsequently, the glands were
transferred to a medium containing insulin plus prolactin. At
different time intervals glands were collected, rinsed with saline, and blot dried. The level of [3H]cortisol in the homogenate
of these glands was determined by thin-layer chromatography
as described (20), except that the LH-20 chromatographic step
was omitted.
Quantitation of mRNAcsn Level. The level of casein mRNA
in the glands was measured by a specific [3H]cDNA probe to
purified 15S mouse casein mRNA (7). Total RNA from the
glands was extracted by the phenol/chloroform method and
RNA excess hybridization followed by SI nuclease digestion
was done as described (7, 16).

RESULTS
Responses of the LA Glands in Medium with Prolactin or
Cortisol Alone. Consistent with our earlier findings (16), the
LA glands contained an extremely low level of mRNAcsn at the
end of a 6-day incubation in a cortisol-free mammogenic medium (Table 1). We have also shown that this low basal level of
mRNA,,n in the LA glands is not influenced by the absence of
Table 1. Level of mRNAmn in LA glands incubated with different
hormone combinations
Culture*

IPrlEPGH, 6 days

ROtl/2t
417

prolactin or progesterone from the medium (16). This indicates
that the casein gene remains in an uninduced condition in the
LA glands. Thus, this whole mammary gland culture model is
suitable to assess the role of prolactin and cortisol on the expression of casein gene in a controlled hormonal environment.

It is evident from the results shown in Table 1 that the LA
glands fail to accumulate mRNAcsn sequences above the basal
level even after 3 days of incubation in insulin/cortisol or insulin/prolactin medium. This indicates that neither prolactin
nor cortisol alone is capable of stimulating mRNA,,n accumulation in the glands. However, when preincubation of the LA
glands in the medium with cortisol or prolactin was followed
by incubation with both prolactin and cortisol, a marked increase in mRNAcsn levels was evident in the glands. These results reveal that the mammary epithelium remains highly responsive to the lactogenic hormone combination even after a
3-day preincubation in absence of cortisol or prolactin, and the
glands require the stimulation of both hormones for expression
of the casein gene.

Effect of Preincubation of the LA Glands with Cortisol
then examined whether the mammary glands
accumulating mRNABn if the preincubation in
insulin/prolactin medium is followed by an incubation with
insulin/cortisol or, conversely, if preincubation with insulin/
cortisol is followed by incubation in insulin/prolactin medium.
When the LA glands were incubated with insulin/cortisol after
a preincubation in insulin/prolactin medium, the mRNAcsn
sequences in the glands became measurable by the cDNA probe
(Table 2). However, the level remained close to the basal condition (0.0009%) seen in the LA glands at the end of step I culture. It is possible that some residual prolactin retained by the
LA glands from the preincubation medium may have acted
synergistically with cortisol, added in the medium subsequently,
and this may account for the slight stimulation. Mammary tissue
may retain residual prolactin at least for the initial 4 hr at a level
sufficient to stimulate RNA synthesis in the explants in vitro
(21). The mRNAcsn levels may have remained low (0.0012%)
at the end of the 3-day culture period due to degradation of the
residual peptide hormone. Because the turnover rate of the
mRNAcsn in the mammary tissue in vitro is fairly low (13), it
is likely that the mRNAn sequences accumulated during the
initial hours of interaction between cortisol and residual proor Prolactin. We
are capable of

lactin may not be lost completely at the end of the 3-day culture
period.
On the other hand, an 18-fold increase in mRNAsn over the
basal level occurred when the LA glands were incubated with
insulin/prolactin for 3 days after preincubation in the insulin/cortisol medium. This pronounced increase cannot be ascribed solely to prolactin action because the results presented

% mRNAcn
0.0009

0.0005
IF, 3 days
832
5.02
0.076
IF, 3 days - IPrlF, 3 days
ND
NDt
IPrl, 3 days
10
0.038
IPrl, 3 days - IPrlF, 3 days
* I, insulin (5 Ag/ml); Prl, prolactin (5 ,ug/ml); E,
(1
ng/ml); P, progesterone (1 ,g/ml); GH, growth hormone (5 ,g/ml);
F, cortisol (5 ,g/ml). The details of the hormones used have been
described elsewhere (16,19). Bovine growth hormone was a gift from
the National Pituitary Agency (National Institute of Arthritis,
Metabolism and Digestive Diseases). All glands were incubated for
first 6 days in IPrlEPGH medium. The concentration of each hormone used during subsequent incubation was the same as described
above.
t Rot112 of purified mRNAcn is 0.0038 mol sec/liter.
t ND, not detectable.

estradiol-17f#

Table 2. Effect of preincubation of LA glands with cortisol or
prolactin on accumulation of mRNAcn sequences after subsequent
incubation in medium containing prolactin or cortisol
Culture*
% mRNAcsn
ROt1/2
NDt
IPrl, 3 days
ND
316.0
IPrl, 3 days - IF, 3 days
0.0012
IF, 3 days
832.0
0.0005
23.4
IF, 3 days - IPrl, 3 days
0.016
* All the glands were first incubated for 6 days in the mammogenic
medium for LA development. Subsequently, these glands were incubated with different hormone combinations as indicated. The
concentration of each hormone was the same as described in Table
1.

t ND, not detectable.
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in the preceding paragraphs show that prolactin alone cannot
stimulate accumulation of the mRNAfn sequences in the LA
glands. Alternatively, it is possible that prolactin acts synergistically with the residual cortisol retained by the LA glands
from the insulin/cortisol preincubation medium. It has been
shown that the mammary gland can take up glucocorticoid (22,
23) and retain it for a prolonged period (15). Thus, the present
results, showing a marked increase of mRNA<,, levels in glands
incubated with prolactin alone after a preincubation with
cortisol, may reflect an action of prolactin in combination with
the residual cortisol. Accordingly, studies were done to assess
the ability of the LA glands to retain residual cortisol from the
preincubation medium under the present experimental conditions.
Cortisol Retention and mRNAcsn Accumulation in the LA
Glands. At 24 hr after removal of cortisol from the medium,
a substantial amount of the steroid hormone was retained by
the LA glands (Fig. 1). Subsequently, the residual cortisol declined, and 6 days after cortisol withdrawal the steroid level
reached 2 ng/g of tissue. During the first 48 hr in insulin/prolactin medium, the mRNA,,s, levels increased 25-fold (0.0006%
to 0.016%) and thereafter it declined to 0.0027% by the day 6.
However, addition of fresh cortisol to the medium at this point,
causes a 20-fold increase in mRNAc.,n levels in the glands in the
presence of prolactin.
Although the level of cortisol decreased >90% within the first
24 hr after its removal (Fig. 1), during the 6-day culture in insulin/prolactin medium the glands retained a measurable level
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FIG. 1. Relationship between the amount of cortisol retained and
mRNA,, accumulated by the LA glands in insulin/prolactin medium
after a 48-hr preincubation with insulin/cortisol. During the last 24
hr of the 48 hr preincubation period [3H]cortisol (5 sCi/ml) was added.
At the end of the preincubation (time 0) the glands were transferred
to the medium containing insulin and prolactin. The medium was
changed every 24 hr and, at different time intervals, the glands were
collected, rinsed with cold saline, and blot dried. Tissue (0.1 g) was
homogenized in 1 ml of deionized water and extracted with ethyl acetate at room temperature. The organic phase was dried under N2,
dissolved in 0.1 ml of chloroform/methanol, 1:1 (vol/vol) containing
5 mg of unlabeled cortisol per ml, and chromatographed on thin-layer
chromatographic plates according to Carson et al. (20). Arrow indicates the time when fresh cortisol (5 ,g/ml) was added to the medium.
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Table 3. Level of cortisol retained by LA glands incubated
with insulin/prolactin after 48-hr preincubation
with insulin/cortisol
Cortisol

Molecules/g

nmol/g
Days with IPrl*

tissue

tissue
X 10-14

0
2.0
12.0
1
0.09
0.54
2
0.02
0.12
4
0.006
0.036
6
0.006
0.036
* Glands were incubated for six days with IPrlEPGH and then for 2
days with IF (see Table 1 for abbreviations and concentrations).
During the last 24 hr of incubation with IF, [3H]cortisol was added
to the medium, and the amount of cortisol retained by the glands
was determined as described in Fig. 1.

of cortisol (Table 3). Recently, it has been shown that addition
of cortisol as low as 3 AM (3 nmol/ml of medium) to insulin/
prolactin medium can cause a 2-fold increase in casein synthesis
in pregnancy mammary explants (24). Accordingly, the amount
of cortisol retained by the glands, at least during the first 48 hr
after its removal, appears to be enough to exert its action along
with prolactin in the medium. Thus, the increase in mRNAcsn
levels 48 hr after cortisol withdrawal may be a result of the interaction between prolactin and the residual cortisol during the
initial period of culture. Under a similar incubation protocol,
casein synthesis also has been shown to increase during the
initial incubation period in insulin/prolactin medium after a
48-hr preincubation of the pregnancy mammary explants in
medium with insulin and cortisol (15). Because the minimum
level of cortisol required for its action with prolactin and the
half-life of the mRNA:,n under the conditions described in Fig.
1 are not known, at present it is not possible to determine
whether the decrease in mRNAcm levels after 48 hr in insulin/prolactin medium is a result of transcriptional block or due
to degradation of the accumulated mRNAcn sequences. Nevertheless, the results clearly demonstrate that cortisol is a limiting factor for expression of the casein gene in insulin/prolactin
medium and its subsequent replenishment can cause an enormous increase in the mRNAcn levels, indicating an absolute
requirement for the glucocorticoid for the functional differentiation of the mammary gland.
DISCUSSION
Studies in animals have revealed that, although cortisol therapy
can promote expression of the casein gene (5-7), suckling, a
stimulus known to maintain an elevated level of circulating
prolactin (25), also influences mRNA,,sn concentration in the
mammary gland in viwo (5). This shows that complexities of the
endocrine environment in the animal make the in vivo model
inadequate for further elucidation of the role of adrenal glucocorticoid and pituitary polypeptide hormones regulating
expression of a specific gene in the mammary cells. The
short-term in vitro model, derived from fragments of mammary gland of pregnant animals, also has serious limitations.
The pregnancy mammary parenchyma, rich in glucocorticoid
receptor (26), is exposed to an increased level of circulating
glucocorticoid in the pregnant animal (27). The glands also
contain abundant casein and its mRNA (28, 29). Consequently,
preincubation in a medium with insulin and cortisol is required
to reduce the endogenous mRNA.. in the explants (12, 13). This
exposure to the steroid hormone is likely to enrich explants in
cortisol because the mammary tissue is known to retain cortisol
for a prolonged period (15). Therefore, a marked stimulation
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of casein gene expression during subsequent short-term inct4
bation of the explants with prolactin may not reflect a stimulatory action of the polypeptide hormone alone (12, 13). Instead,
it is more likely that the results reflect a synergistic action of
prolactin and the residual cortisol. Results of the present and
other recent studies (15) seem to confirm this possibility. Thus,
it is difficult to delineate the discrete role of the polypeptide
and steroid hormones for the casein gene expression by using
an in vitro model derived from the fragments of pregnancy
mammary tissue.
The two-step culture model of the whole mammary organ
seems to offer uniquely suitable conditions because pregnancy-like LA morphogenesis of the parenchyma is accomplished in a corticosteroid-free medium in vitro. The mammary
cells in the LA glands remain in an uninduced state, eliciting
only a basal level of mRNAcsn. This then eliminates preincubation of the glands with cortisol, a step required to reduce the
endogenous mRNAsn in explants from pregnancy mammary
tissue. Moreover, the lack of requirement for preincubation
with cortisol also avoids the complex problem of residual cortisol
carryover into the step II medium. The present results demonstrate that LA glands not preincubated with cortisol fail to
elicit mRNAa,, in medium with cortisol or prolactin, indicating
that neither the steroid nor the polypeptide hormone alone is
capable of stimulating the casein gene in the LA whole mammary organ. However, the glands remain competent and accumulate abundant mRNAc,. sequences when exposed to both
cortisol and prolactin during subsequent incubation. Thus,
future studies using this two-step culture model of the whole
mammary organ should provide elucidation of the complex
interactions between the steroid and the polypeptide hormones
regulating mammary cell differentiation. Until then, assigning
specific regulatory function to either of the two lactogenic
hormones at the transcriptional or posttranscriptional level of
control of the casein gene will remain conjecture.
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